[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Alpert et al., 2021 - Google Patents

Mapping of Local Cerebral pH with Positron Emission Tomography

Alpert et al., 2021

Document ID
11077970423522781359
Author
Alpert N
Senda M
Correia J
Publication year
Publication venue
Radiopharmaceuticals and Brain Pathophysiology Studied with Pet and Spect

External Links

Snippet

Animal studies have demonstrated disturbances in acid/base balance resulting from experimental ischemic injury. Local alterations in brain pH may also arise in association with neoplastic tissue. The pH of the tissue environment may also play a role in radiation therapy …
Continue reading at www.taylorfrancis.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50—Clinical applications
    • A61B6/507—Clinical applications involving determination of haemodynamic parameters, e.g. perfusion CT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules

Similar Documents

Publication Publication Date Title
Phelps et al. Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin
Dickie et al. Measuring water exchange across the blood-brain barrier using MRI
Jalloh et al. Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings
Powers et al. Positron emission tomography and its application to the study of cerebrovascular disease in man.
Larsen et al. Blood flow through human adipose tissue determined with radioactive xenon
Gjedde et al. Rapid simultaneous determination of regional blood flow and blood‐brain glucose transfer in brain of rat 1
US5357959A (en) Altered dipole moment magnetic resonance imaging method
GOULD et al. Measurement of Regional: Myocardial Blood Flow in Dogs by Ultrafast CT
Rottenberg et al. In vivo measurement of brain tumor pH using [11C] DMO and positron emission tomography
Donegan et al. Cerebrovascular hypoxic and autoregulatory responses during reduced brain metabolism
Rottenberg et al. In vivo measurement of regional brain tissue pH using positron emission tomography
Brooks et al. Measurement of regional cerebral pH in human subjects using continuous inhalation of 11CO2 and positron emission tomography
Cruz et al. Functional imaging of focal brain activation in conscious rats: impact of [14C] glucose metabolite spreading and release
Arai et al. Oxygen-sensitive MRI: a predictive imaging biomarker for tumor radiation response?
Poulsen et al. In vivo estimation of cerebral blood flow, oxygen consumption and glucose metabolism in the pig by [15O] water injection,[15O] oxygen inhalation and dual injections of [18F] fluorodeoxyglucose
BASRAN et al. A noninvasive technique for monitoring lung vascular permeability in man
DeWitt et al. Stable xenon versus radiolabeled microsphere cerebral blood flow measurements in baboons.
Youn et al. Assessment of extracellular glucose distribution and glucose transport activity in conscious rats
Møller Effects of growth hormone on fluid homeostasis. Clinical and experimental aspects
Lear et al. Autoradiographic measurement of cerebral lactate transport rate constants in normal and activated conditions
Artru Reduction of cerebrospinal fluid pressure by hypocapnia: changes in cerebral blood volume, cerebrospinal fluid volume, and brain tissue water and electrolytes
Alpert et al. Mapping of Local Cerebral pH with Positron Emission Tomography
Alpert et al. In-vivo imaging of mitochondrial depolarization of myocardium with positron emission tomography and a proton gradient uncoupler
Kyparos et al. Assessment of Brown Adipose Tissue Activity in Rats by 99m Tc-Sestamibi Uptake.
Poussier et al. ECG-triggered 18 F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox